CD8 T cells lacking Tet1/3 preferentially differentiate into short-lived effector and effector memory cells following acute ...
Ten years of substantial work by Université de Montréal immunologist Nathalie Labrecque's team at the Montreal Clinical ...
Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United ...
CD8-positive T cells are a critical subpopulation of MHC class I-restricted T cell and are mediators of adaptive immunity. They include cytotoxic T cells, which are important for killing cancerous ...
A groundbreaking study published in Research (2025, DOI: 10.34133/research.0545) has elucidated the molecular mechanisms by which protein phosphatase 2A (PP2A) regulates CD8+ T cell-mediated immune ...
A phase 3 trial of nemvaleukin alfa in with Keytruda for patients with platinum-resistant ovarian cancer will not continue on ...
Chinese scientists have developed a molecule which helps with the "last mile" delivery of antigens in cells and can act as an adjuvant to enhance the effect of vaccines for preventing infectious ...
Ten years of substantial work by Nathalie Labrecque's team at the Montreal Clinical Research Institute (IRCM) and the ...
Dr. Hong Jiang presented at 7th Treg-Directed Therapies Summit. BOSTON, MA, UNITED STATES, March 26, 2025 /EINPresswire / -- Avotres proudly a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback